LTR Pharma Limited (ASX:LTP)
Australia flag Australia · Delayed Price · Currency is AUD
0.4650
+0.0150 (3.33%)
At close: Jul 31, 2026

LTR Pharma Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
8552109---
Market Cap Growth
35.38%-51.74%----
Enterprise Value
5918103---
Last Close Price
0.470.290.78---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
74.7134.792219.25---
PB Ratio
3.151.6736.98---
P/TBV Ratio
3.151.6736.98---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
51.9212.212096.41---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
------8.81
Net Debt / Equity Ratio
-0.96-1.01-1.05-0.83-1.08-5.22
Net Debt / EBITDA Ratio
2.645.210.45---
Net Debt / FCF Ratio
3.707.150.611.123.36-7.33
Asset Turnover
0.040.090.02-0.01-
Quick Ratio
56.7045.767.8684.374.110.32
Current Ratio
57.4745.787.8684.374.110.32
Return on Equity (ROE)
-29.27%-32.47%-277.45%-75.74%-118.83%-
Return on Assets (ROA)
-19.71%-21.45%-158.79%-41.36%-47.61%-
Return on Capital Employed (ROCE)
-36.40%-19.40%-236.00%-69.30%-57.40%70.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-10.59%-10.66%-6.40%---
FCF Yield
-8.24%-8.48%-4.69%---
Buyback Yield / Dilution
-23.89%-19.96%46.34%---